173, no. 15 (2013): 1458–1460.
15. Стивен Браун, интервью автора.
16. C. Lee Ventola, “Direct-to-Consumer Pharmaceutical Advertising: Therapeutic or Toxic?” Pharmacy and Therapeutics 36, no. 10 (2011): 669–684; Samantha Huo et al., “Treatment of Men for ‘Low Testosterone’: A Systematic Review,” PLOS ONE 11, no. 9 (2016): e0162480.
17. Hoberman, Testosterone Dreams, 120.
18. Metzger and Burnett, “Impact of Recent FDA Ruling.”
19. Shalender Bhasin et al., “Testosterone Therapy in Adult Men with Androgen Defi ciency Syndromes: An Endocrine Society Clinical Practice Guidline,” Journal of Clinical Endocrinology and Metabolism 95, no. 6 (2010): 2536–2559; Frederick Wu et al., “Identifi cation of Late-Onset Hypogonadism in Middle-Aged and Elderly Men,” New England Journal of Medicine 363, no. 2 (2010): 123–135; G. R. Dohle et al., “Guidelines on Male Hypogonadism,” European Association of Urology, 2014, http://uroweb.org/wp-content/uploads/18-Male-Hypogonadism_LR1.pdf.
20. Joseph Scott Gabrielsen et al., “Trends in Testosterone Prescription and Public Health Concerns,” Urologic Clinics of North America 43, no. 2 (2016): 261–271; Katherine Margo and Robert Winn, “Testosterone Treatments: Why, When, and How?” American Family Physician 73, no. 9 (2006): 1591–1598.
21. L. M. Schwartz and S. Woloshin, “Low ‘T’ as in ‘Template’: How to Sell Disease,” JAMA Internal Medicine 173, no. 15 (2013): 1460–1462.
22. W. J. Bremner et al., “Loss of Circadian Rhythmicity in Blood Testosterone Levels with Aging in Normal Men,” Journal of Clinical Endocrinology and Metabolism 56, no. 6 (1983): 1278–1281.
23. Fred Sattler et al., “Testosterone and Growth Hormone Improve Body Composition and Muscle Performance in Older Men,” Journal of Clinical Endocrinology and Metabolism 94, no. 6 (2009): 1991–2001.
24. Доктор Александр Пастушак, интервью автора.
25. A. M. Matsumoto, “Effects of Chronic Testosterone Administration in Normal Men: Safety and Effi cacy of High Dosage Testosterone and Parallel Dose-Dependent Suppression of Luteinizing Hormone, Follicle-Stimulating Hormone, and Sperm Production,” Journal of Clinical Endocrinology and Metabolism 70, no. 1 (1990): 282–287.
26. L. Frederiksen et al., “Testosterone Therapy Decreases Subcutaneous Fat and Adiponectin in Aging Men,” European Journal of Endocrinology 166 (2012): 469–476.
27. Shehzad Basaria et al., “Adverse Events Associated with Testosterone Administration,” New England Journal of Medicine 363, no. 2 (2010): 109–122; S. Basaria et al., “Effects of Testosterone Administration for 3 Years on Subclinical Atherosclerosis Progression in Older Men with Low or Low-Normal Testosterone Levels: A Randomized Clinical Trial,” Journal of the American Medical Association 314, no. 6 (2015): 570–581.